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Mathematical modeling of vaccinations: modified SIR model, 
vaccination effects, and herd immunity 
 
 
Tina Huyền Lương  





Despite the clear effects and benefits of vaccinations on a population, there are many individuals that choose 
to not vaccinate for non-medical reasons, giving rise to anti-vaccination movements and vaccine hesitancy. 
This paper introduces the different types of vaccines and the effects of vaccines in the body and provides an 
examination of a case study of the 2019 Pacific Northwest measles outbreak. The outbreak is modeled using 
a proposed modified SIR model and solved using the Fourth-Order Runge-Kutta method. The results suggest 
that around day 20, almost the entire population becomes infected with the vaccine-resistant strain, which 
outcompetes the wild-type strain, and the vaccination rate of Clark and Multnomah county suggest that the 
herd immunity effect does not occur. Many limitations exist for the proposed modified SIR model, with two 





Before vaccinations in the 20th century, there have been over half a million cases of measles, over 150,000 
cases of mumps, and around 50,000 cases of smallpox annually, and since the introduction of vaccines, the 
number of cases for measles, mumps, and smallpox decreased by 99.9%, 98.7%, and 100% as of 2009, 
respectively.1 Time and time again, vaccines have displayed their ability to eradicate diseases and decrease 
disease occurrences; however, many individuals still find themselves hesitant of vaccinations due to many 
factors such as vaccine controversy, cultural/religious/personal beliefs, past experience, family history, 
personal feelings of control, community and peer influence, and so forth. To observe the effects of vaccination 
and herd immunity on the number of disease occurrences in a population, an examination of a case study of 
the 2019 Pacific Northwest measles outbreak is conducted, and the outbreak is modeled by a modified SIR 
model. 
 
VACCINATION: TYPES AND EFFECTS 
 
Types of vaccines 
 
Many different types of vaccines have been developed to address different concerns and conditions, such as 
immune response, infection dynamics, environment, and so forth. The most commonly seen vaccines are 
live, attenuated, inactivated, subunit, conjugate, and toxoid vaccines. 
 
1) Live, attenuated vaccines are composed of a weakened version of the live, infectious agent.  
e.g. MMR vaccine (measles, mumps, rubella), varicella vaccine (chickenpox) 
2) Inactivated vaccines are composed of the dead infectious agent. 
e.g. inactivated poliovirus vaccine, flu shot, hepatitis A vaccine   
3) Subunit and conjugate vaccines include only parts of the infectious agent (like its antigen, protein, 
sugar, etc.), rather than the whole microbe.2  
e.g. part of DTaP vaccine (whooping cough), Hib (Haemophilus influenzae type B) vaccine 
4) Toxoid vaccines are composed of the weakened version of the toxins that certain bacteria release. 
Toxins are weakened to the point where they cannot cause illness.2  
e.g. tetanus, diphtheria 
 
The intersections of the body’s immune response and vaccinations 
 
To better understand how vaccines work, one would first need to recognize the ways in which the human 
body tackles illness and builds immunity. An over-generalized explanation is given below.  
 
Infectious agents, such as bacteria or viruses, invade the body and replicate, causing an infection and leading 
to an illness. To begin, immune cells rush to the infected area and induce inflammation, while macrophages 
and neutrophils engulf the infectious agents through endocytosis, digest them using enzymes, present their 
antigens on the cell surface, and secrete signaling molecules to recruit more immune cells. When the 
infectious agent is a virus, infected host cells secrete interferons (special proteins) that signal uninfected, 
neighboring cells to release substances that inhibit the reproduction of viruses and decrease the permeability 
of cells.3 T-cells and B-cells are also present and attempting to attack infected cells and infectious agents, 
respectively. 
 
As all this is occurring, dendritic cells collect antigens from the infectious agents, display them on its surface, 
and initiate the body’s adaptive immune response by presenting the antigens to naive T-cells in secondary 
lymphoid organs.4  The exposed naive T-cells then replicate to produce a variety of T-cells, including memory 
and helper T-cells, and helper T-cells go on to activate naive B-cells. B-cells reproduce to create memory B-
cells, which remember the appropriate antibody needed for the specific antigen of an infectious agent and 
remain in the body after infection, and plasma cells, which are responsible for releasing an influx of 
antibodies.3 T-cells are a part of the body’s cell-mediated immune response and target infected host cells, 
whereas B-cells directly target the infectious agent and release antibodies to combat antigens on the agent’s 
surface and any free-flowing antigens in the blood or lymph.3  
 
Though seemingly efficient, it typically takes around seven to ten days after the exposure to the antigen for B-
cells to respond with the appropriate antibody because each B-cell creates only one specific configuration of 
the antibody and antigen receptor, corresponding to only one specific antigen. However, depending on the 
illness, seven to ten days may be too late for the body to fight off the illness alone or for the individual to not 
develop complications. Since memory B-cells remain in the body and await re-exposure to the antigen, the 
development of memory B-cells serves as the goal of vaccinations. Vaccines work to help an individual build 
immunity by imitating an infection. From the pseudo-infection, the body undergoes its immune response, 
producing memory T- and B-cells in the process. In the event of a true infection, the immune system views 
this as a repeated encounter, and the memory B-cells rapidly produce a surge of the appropriate, 
corresponding antibodies to target the antigens of the infectious agents. This allows the individual to skip the 




While vaccines can effectively prevent illness, not everyone can become vaccinated due to age, illness, allergy, 
compromised immune system, etc. Nevertheless, unvaccinated individuals can benefit from the immunity of 
vaccinated individuals via herd immunity. Herd immunity is a form of indirect protection for susceptible 
individuals in a population where having enough vaccinated individuals in the population decrease the 
number of susceptible hosts for an infectious agent, thus preventing or limiting the spread of disease. If cases 
of the disease do occur, they are often easier to isolate or contain.  
 
PROPOSED MODIFIED SIR MODEL 
 
Many models have been produced to predict the spread of infectious disease and demonstrate possible 
outcomes given a set of circumstances. Most generally known, the SIR model involves the examination of the 
number of people with respect to time in three defined categories: susceptible (S), infected (I), and recovered 
(R). Dr. Angela McLean and Dr. Almut Scherer introduced the following system of differential equations for 
a modified SIR model, accounting for the existence of vaccine-resistant strains of infectious agents and the 
addition of a category for vaccinated individuals (V).  
 





= 𝑝𝜇𝑁 − 𝛽*(1 − 𝜑*)𝑉𝐼* − 𝛽0(1 − 𝜑0)𝑉𝐼0 − 𝜇𝑉 
𝑑𝑆
𝑑𝑡
= (1 − 𝑝)𝜇𝑁 − (1 − 𝑄)𝛽*𝑆𝐼* − 𝑄𝛽*𝑆𝐼* − 𝛽0𝑆𝐼0 − 𝜇𝑆 
𝑑𝐼*
𝑑𝑡
= (1 − 𝑄)𝛽*𝑆𝐼* + 𝛽*(1 − 𝜑*)𝑉𝐼* − 𝛾𝐼* − 𝜇𝐼* 
𝑑𝐼0
𝑑𝑡
= 𝑄𝛽*𝑆𝐼* + 𝛽0𝑆𝐼0 + 𝛽0(1 − 𝜑0)𝑉𝐼0 − 𝛾𝐼0 − 𝜇𝐼0 
𝑑𝑅
𝑑𝑡
= 𝛾𝐼* + 𝛾𝐼0 − 𝜇𝑅 
 
 
where the meanings of the above parameters and variables are displayed in Table 1 below.  
 
 
Table 1. Definition of parameters and variables for modified SIR model differential equations.5 
Parameter/Variable Meaning 
𝑝 Fraction of individuals vaccinated at birth 
𝜇	and	𝛾 Death and recovery rate, respectively 
𝛽*	and	𝛽0 Transmission/effective-contact rate for wild-type strain; for vaccine-resistant strain 
𝜑*	and	𝜑0 Fraction of infections with wild-type strain; with vaccine-resistant strain 
𝑄 Rate of mutation/mutation probability 
𝑉(𝑡) Number of vaccinated individuals at a given time 
𝑆(𝑡) Number of susceptible individuals at a given time 
𝐼*(𝑡) Number of infected individuals with wild-type strain at a given time 
𝐼0(𝑡) Number of infected individuals with vaccine-resistant strain at a given time 
𝑅(𝑡) Number of recovered/permanently immune individuals at a given time 
𝑁(𝑡) Total population (sum of 𝑉(𝑡), 𝑆(𝑡), 𝐼*(𝑡), 𝐼0(𝑡), and 𝑅(𝑡)) 
 
The proposed modified SIR model assumes the following: 
 
§ Immunity gained from infection of either strain (vaccine-resistant or wild-type) grants life-long 
immunity against all strains for the individual.  
§ Susceptible and vaccinated individuals can be infected by either strain, thus taking into 
consideration the waning immunity of vaccines.  
§ With enough cases, the vaccine-resistant strain is not at a selective disadvantage and takes over as 
the primary strain infecting individuals.  
§ General assumptions of SIR models hold (population mixes homogeneously, only way to leave 
susceptible category is by becoming infected, etc.).   
 
CASE STUDY: 2019 PACIFIC NORTHWEST MEASLES OUTBREAK 
 
On January 3rd, 2019, the first case of measles was confirmed in a child that returned from a trip to Ukraine, 
and the measles outbreak began in Clark county, Washington.6 By January 18th, 2019, the Clark County 
Council Chair, Eileen Quiring, declared a public health emergency due to the measles outbreak, and 
Governor Jay Inslee declared a state of emergency in Washington on January 25th after the number of 
measles cases reached 25 with 12 suspected cases pending.6-7 There have been 53 exposure sites identified, 
ranging from health care facilities, schools, and childcare centers to workplaces, retail stores, and other public 
places.6 As of April 29th, 2019, Clark County Public Health declared that the measles outbreak has 
concluded.6 
 
Now, this case study will focus specifically on the cases examined in Clark county, Washington and 
Multnomah county, Oregon. Using the data available on April 29th, 2019, Clark and Multnomah county has 
65 cases in which the affected individuals are unvaccinated, three cases in which the affected individuals 
received one dose of the MMR vaccine, and seven cases in which the immunization status is unverified.6,8 
Some critical assumptions are made for this study: 
 
§ The unverified cases are assumed to be unvaccinated, thus bringing the total unvaccinated cases to 
72 and vaccinated cases to three. 
§ At time 𝑡 = 0, let the 72 unvaccinated cases and three vaccinated cases all be developed at the same 
time. 
§ Suppose the vaccinated cases are cases in which the individuals are infected with the vaccine-resistant 
strain and the unvaccinated cases are cases in which the individuals are infected with the wild-type 
strain. 
 
Setting: defining parameters and initial values 
 
As of July 1st, 2018, the populations of Clark and Multnomah county are 481,857 people and 811,880 
people, with a vaccination rate of 0.81% and 0.87%, respectively, for one dose of MMR.9-11 Assuming all 









= 8.47653 × 10GH	 
 
where 𝑣A, 𝑣B are the vaccination rates and 𝑁A,𝑁B are the populations for Multnomah and Clark county.  The 
death rate for measles 𝜇 is two out of a thousand deaths per year, or 5.47945	 ×	10GJ per day.12 The recovery 
rate for measles 𝛾 is 5.0	 ×	10GK per day, the reciprocal of the duration of infection, which is approximately 
twenty days.13  
 
Assuming the effective contact rate for the wild-type strain 𝛽* and vaccine-resistant strain 𝛽0 are the same, 
the rate is obtained from the equation below. 
 






= 5.79716 × 10GR	𝑡𝑟𝑎𝑛𝑠𝑚𝑖𝑠𝑠𝑖𝑜𝑛𝑠/𝑐𝑜𝑛𝑡𝑎𝑐𝑡	 
 
where 𝑅L is the basic reproduction number for measles, 𝛾 is the recovery rate, and 𝑁MNMOP is the combined 
population of Multnomah and Clark county. For measles, the basic reproduction number is between 12-18, 
and the average of the two values was chosen for the calculation.14 Furthermore, the probability of the measles 
virus mutating 𝑄 is approximately 1.2 × 10G\ mutations per replication.15 
 
Using the data obtained from the 2019 Pacific Northwest measles outbreak as of April 29th, 2019 and 
supposing the unconfirmed cases are unvaccinated cases, there are a total of 72 unvaccinated cases and three 
vaccinated cases, where the person received one dose of MMR.6,8 Let the three vaccinated individuals be 
infected by the vaccine-resistant strain. Then, the fraction of individuals infected by the wild-type strain 𝜑* 












= 4.0 × 10GK 
 
Now, the initial state for each category will be based on the data from the 2019 Pacific Northwest measles 
outbreak dated April 29th, 2019. From the data, the initial number of infected individuals with the wild-type 
strain 𝐼*(0) and the vaccine-resistant strain 𝐼0(0) are 72 people and three people, respectively. The initial 
value for the number of vaccinated individuals is calculated by multiplying the total population 𝑁MNMOP by the 
fraction of vaccinated individuals at birth 𝑝 and subtracting the initial number of infected individuals with the 
vaccine-resistant strain. That is, 
 
𝑉(0) = 𝑝 × 𝑁MNMOP − 𝐼0(0) = (8.47653 × 10GH)(1,293,737) − 3 = 1.096637 × 10J	𝑝𝑒𝑜𝑝𝑙𝑒	 
 
It follows that the initial number of susceptible individuals 𝑆(0) is 
 
𝑆(0) = 𝑁MNMOP − 𝑉(0) − 𝐼0(0) − 𝐼*(0) = 1.97025 × 10h	𝑝𝑒𝑜𝑝𝑙𝑒 
 
and the initial number of recovered individuals 𝑅(0) is zero. All the calculated values above for each 
parameter and initial value is displayed in the table below. 
 
Table 2. Value given to each parameter and initial state12-13,15 
Parameter Value Units 
𝑝 8.47653 × 10GH - 
𝜇 5.47945 × 10GJ dayGH  
𝛾 5.0 × 10GK dayGH 
𝛽*	and	𝛽0 5.79716 × 10GR transmissions/contact 
𝜑*	and	𝜑0 9.6 × 10GH	𝑎𝑛𝑑	4.0 × 10GK - 
𝑄 1.2 × 10G\ mutations/replication 
𝑉(0) 1.096637 × 10J people 
𝑆(0) 1.97025 × 10h people 
𝐼*(0) 72 people 
𝐼0(0) 3 people 
𝑅(0) 0 people 
 
Solving the Modified SIR Model using the Fourth-Order Runge-Kutta Method  
 
The Fourth-Order Runge-Kutta method is a method used to find an approximate solution of initial value 
problems of the form 
bu(M)
bM
= 𝑓w𝑡, 𝑦(𝑡)y with 𝑦(𝑡L) = 𝑦L, where 𝑦	can be a vector-valued function. For this 


























𝑝𝜇𝑁 − 𝛽*(1 − 𝜑*)𝑉𝐼* − 𝛽0(1 − 𝜑0)𝑉𝐼0 − 𝜇𝑉
(1 − 𝑝)𝜇𝑁 − (1 − 𝑄)𝛽*𝑆𝐼* − 𝑄𝛽*𝑆𝐼* − 𝛽0𝑆𝐼0 − 𝜇𝑆
(1 − 𝑄)𝛽*𝑆𝐼* + 𝛽*(1 − 𝜑*)𝑉𝐼* − 𝛾𝐼* − 𝜇𝐼*
𝑄𝛽*𝑆𝐼* + 𝛽0𝑆𝐼0 + 𝛽0(1 − 𝜑0)𝑉𝐼0 − 𝛾𝐼0 − 𝜇𝐼0







This method involves finding four approximations of slopes 𝐾`, 1 ≤ 𝑖 ≤ 4, for each of the population 
functions per time step: one at the beginning, two at the midpoint, and one at the end of the time step. The 
Fourth-Order Runge-Kutta method generates an approximation 𝑦 of the true state of the system 𝑦(𝑡) at a 
time 𝑡L ≤ 𝑡 ≤ 𝑇 through an iteration and is given by 
 
𝑦dH = 𝑦 +
ℎ
6
(𝐾H + 2𝐾K + 2𝐾e + 𝐾\) 
 
such that  
 
𝐾H = 𝑓(𝑡, 𝑦) 














𝐾\ = 𝑓(𝑡 + ℎ, 𝑦 + ℎ𝐾e) 
 
0 < ℎ < 1 is the step size chosen and 𝑡 = 𝑡L + 𝑘ℎ, 𝑘 ≥ 0.16 
 




|𝑦(𝑡) − 𝑦| < 𝐶ℎ\ 
 
and decaying by a rate of ℎ\, with 𝐶 as a constant.16 
 
Now, given the system of differential equations in the modified SIR model proposed, the Fourth-Order 
Runge-Kutta method was used to approximate the solution of the system from the time 𝑡 = 0 to 100 days. 
The following code was ran on GNU Octave using a step size ℎ of 0.01 and the defined values given in Table 
2. 
 
 1  function RK4_Method(h,p,mu,gm,bw,br,fw,fr,Q) %Main Program 
 2    t0=0; tf=100; t=t0:h:tf; n=length(t); 
 3    param=[p;mu;gm;bw;br;fw;fr;Q]; 
 4    P=zeros(5,n); %state of population P=[V,S,Iw,Ir,R] at each time snapshot 
 5    P0=[1096637;197025;72;3;0]; P(:,1)=P0; %initial state  
 6    for k=1:n-1 
 7       P(:,k+1)=RK4(h,P(:,k),param); 
 8    end 
 9    figure(1);  
10    plot(t,P(1,:),'g',t,P(2,:),'r',t,P(3,:),'c',t,P(4,:),'m',t,P(5,:),'b'); 
11    xlabel('Time [days]'); ylabel('Population [number of people]'); 
12    h=legend('vaccinated','susceptible (unvaccinated)','infected with wild-type     
      strain','infected with vaccine-resistant strain','recovered'); 
13    legend(h,'location','northeastoutside'); set (h,'fontsize', 8.5);  
14  end %End Main Program 
15 
16  function y=RK4(h,y,param) %RK4 Method 
17    K1=f(y,param); 
18    K2=f(y+(h/2)*K1,param); 
19    K3=f(y+(h/2)*K2,param); 
20    K4=f(y+h*K3,param); 
21    y=y+(h/6)*(K1+2*K2+2*K3+K4); 
22  end 
23 
24  function y=f(y,param) %Incorporating system of DE 
25    p=param(1); mu=param(2); gm=param(3); bw=param(4);  
26    br=param(5); fw=param(6); fr=param(7); Q=param(8); 
27    V=y(1); S=y(2); Iw=y(3); Ir=y(4); R=y(5); N=V+S+Iw+Ir+R; 
28    y=[p*mu*N-bw*(1-fw)*V*Iw-br*(1-fr)*V*Ir-mu*V; 
29    (1-p)*mu*N-(1-Q)*bw*S*Iw-Q*bw*S*Iw-br*S*Ir-mu*S; 
30    (1-Q)*bw*S*Iw+bw*(1-fw)*V*Iw-gm*Iw-mu*Iw; 
31    Q*bw*S*Iw+br*S*Ir+br*(1-fr)*V*Ir-gm*Ir-mu*Ir; 
32    gm*Iw+gm*Ir-mu*R]; 







Solving the system of differential equations using the Fourth-Order Runge-Kutta method and the code above 
gave the following figure. Figure 1 displays five curves, with each representing the approximation for the 
number of vaccinated, susceptible, infected with wild-type strain, infected with vaccine-resistant strain, or 
recovered individuals in the combined population of Clark and Multnomah county on any day from zero to 
100 days. These approximations for the different population functions suggest that around day 20, almost the 
entire population becomes infected with the vaccine-resistant strain. With a large vaccinated population 
initially, the vaccine-resistant strain outcompetes the wild-type strain, rendering the vaccines for measles 
ineffective. In the case of a large unvaccinated population, the wild-type strain outcompetes the vaccine-
resistant strain, as indicated in Figure 2, and the entire population becomes infected as well. Based on the 
results, a vaccination rate of approximately 96% was not enough to benefit from herd immunity effects and 
contain the measles outbreak, especially since a vaccine-resistant strain was introduced into the population.  
 
 
Figure 1. RK4 approximation of the number of vaccinated, unvaccinated, infected, and recovered individuals 




Figure 2. RK4 Approximation of modified SIR model solution given initial unvaccinated population 𝑉(0) =
1,096,637 people, initial vaccinated population 𝑆(0) = 197,025	people, and fraction of population at 
vaccinated at birth 𝑝 = 0.152347.  
CONCLUSION 
 
While the death rate for measles is low, two deaths per 1,000 cases, 30% of measles cases have reported 
having one or more complications, as measles suppresses an infected individual’s immune system and causes 
them to become prone to infection.17 More common, minor complications are diarrhea and ear infections, 
which affect one out of ten cases, though the ear infections can fester and lead to permanent hearing loss.18 
Severe complications due to measles consist of pneumonia, affecting one out of 20 cases, and encephalitis, 
affecting one of 1,000 cases.18 Pneumonia is the most common cause of death in young children affected by 
measles, and encephalitis (brain swelling) leads to convulsions and can cause deafness or neurological 
damage.18 Before vaccinations in the 20th century, there have been over half a million cases of measles, and 
since the introduction of vaccines, the number of cases for measles decreased by 99.9%.1  
 
Mathematical models can help with creating visual representation and predicting long-term behavior, but 
there are many limitations to using them. For instance, the modified SIR model used to model the effects of 
measles on a population contained many assumptions such as homogeneous mixing of the population, no 
birth and migration, no spatial consideration, and so forth. Homogeneous mixing of the population resulted 
in there being more infected individuals than what would likely happen in a realistic scenario. In real 
situations, the population does not mix homogeneously, and cases of infection are isolated to prevent further 
spread of disease. Having a large vaccinated population and a vaccine-resistant strain of measles introduced 
negated herd immunity effects and rendered the MMR vaccine ineffective in the case study. Furthermore, 
the model assumes that when the measles strain mutates, a vaccine-resistant strain is guaranteed to be 
produced, when in real situations, the probability of such a strain being formed from a mutation is low in a 
largely vaccinated population. Despite the limitations, mathematical models used for simulations are 
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